Abstract:The identification of drug-target interactions in web lab is costly and time-consuming. Computational approaches become important to help identifying potential candidates for laboratory experiments. However, they usually involve solving optimization problems or assuming statistical distribution based on prior knowledge, and may require estimating tunable parameters. This paper is motivated by the concepts behind “follow-on” drugs. They are the drugs developed by drug companies to substitute the pioneering drug which was firstly discovered and patented for a specific target and determined a new therapeutic class. There are three observations from “follow-on” drugs. The first observation has been used by many existing methods: drugs interacting with a common target usually have higher similar scores (e.g. the similarity score in terms of chemical structure). The second one is that a drug candidate for a specific target gains more attention if it is more similar to those drugs interacting with the target than other known drugs, even though the similarity score is low. Lastly, people intuitively tend to design a “follow-on” drug for the targets already having more drugs because of less cost and less risk. In our approach, the above observations are translated into more evidences for predicted drug-target interaction. Designing an interaction tendency index to characterize these observations, we propose the similarity-rank-based predictor (SRP). Unlike other models, SRP is a non-parametric model and requires neither solving an optimization problem nor prior statistical knowledge. Based on real benchmark datasets, we show that our model is able to achieve higher accuracy than the two most recent models and our approach is able to cope with two real predicting scenario of missing interactions.

An Efficient Drug-Target Interaction Mining Algorithm in Heterogeneous Biological Networks.

Predicting Drug-Target Interaction for New Drugs Using Enhanced Similarity Measures and Super-Target Clustering.

SRP: A Concise Non-Parametric Similarity-Rank-based Model for Predicting Drug-Target Interactions

Predicting Drug-Target Interactions Between New Drugs and New Targets via Pairwise K-nearest Neighbor and Automatic Similarity Selection.

Integrated Multi-Similarity Fusion and Heterogeneous Graph Inference for Drug-Target Interaction Prediction

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

Subgraph-Oriented Heterogeneous Drug-Target Interaction Identification.

Identifying drug-target interactions via heterogeneous graph attention networks combined with cross-modal similarities

A Machine Learning-Based Biological Drug–Target Interaction Prediction Method for a Tripartite Heterogeneous Network

Drug-Target Interaction Prediction Based on Heterogeneous Networks

Measuring drug similarity using drug–drug interactions

HNEDTI: Prediction of Drug-Target Interaction Based on Heterogeneous Network Embedding

Drug-target Interaction Prediction: Databases, Web Servers and Computational Models.

An End-to-end Heterogeneous Graph Representation Learning-Based Framework for Drug-Target Interaction Prediction.

A Metagraph-Based Model for Predicting Drug-Target Interaction on Heterogeneous Network

A Biological Feature and Heterogeneous Network Representation Learning-Based Framework for Drug–Target Interaction Prediction

Predicting Drug-Target Interactions over Heterogeneous Information Network

Predicting combinations of drugs by exploiting graph embedding of heterogeneous networks

Association Mining to Identify Microbe Drug Interactions Based on Heterogeneous Network Embedding Representation

A heterogeneous graph neural network with automatic discovery of effective metapaths for drug-target interaction prediction

Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features.